2016
DOI: 10.1007/s10875-016-0233-1
|View full text |Cite
|
Sign up to set email alerts
|

Is Pulmonary non-Tuberculous Mycobacterial Disease Linked with a High Burden of Latent Cytomegalovirus?

Abstract: Cytomegalovirus (CMV) establishes lifelong infections with episodes of active replication. We hypothesized that recurrent CMV replication in older individuals may suppress protective immune responses to non-tuberculous mycobacteria (NTM) and so potentiate pulmonary disease. Accordingly, levels of antibodies to three CMV antigen preparations were higher in NTM patients than in age-matched controls. This did not reflect broad-spectrum B cell activation as total immunoglobulin levels were not equivalently increas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
2

Year Published

2018
2018
2022
2022

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 20 publications
0
8
2
Order By: Relevance
“…One study associated CMV antibody levels with TNF‐α and IL‐6 in sera from young and elderly individuals . We found no correlation between CMV antibody levels and sTNFR1 in healthy controls or patients with nontuberculous mycobacteria, and there was no consistent pattern here in RTR or healthy adults. Our data suggest that CMV antibody is not a surrogate marker of ‘inflammaging’ .…”
Section: Discussioncontrasting
confidence: 79%
See 2 more Smart Citations
“…One study associated CMV antibody levels with TNF‐α and IL‐6 in sera from young and elderly individuals . We found no correlation between CMV antibody levels and sTNFR1 in healthy controls or patients with nontuberculous mycobacteria, and there was no consistent pattern here in RTR or healthy adults. Our data suggest that CMV antibody is not a surrogate marker of ‘inflammaging’ .…”
Section: Discussioncontrasting
confidence: 79%
“…The use of antibodies as a metric of the burden of CMV is complicated by increased levels in older individuals, demonstrated in the Australian population. 21 Here, transplantation overcame the effect of age, but the levels of CMV antibody were elevated in RTR and increased with time posttransplant. This is consistent with episodic subclinical CMV reactivations in patients on antirejection therapy, as evidenced by the detection of CMV DNA in some (not all) RTR.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…Accordingly we find no concordance between levels of soluble TNF receptors and CMV antibodies in HIV patients stable on ART [19] or older individuals with or without NTM disease [49]. We conclude that circulating pro-inflammatory markers are a poor metric of the footprint of CMV in these situations.…”
Section: And Inflammagingcontrasting
confidence: 59%
“…CMV has been linked with several diseases of aging. In addition to cardiovascular disease (CVD), we demonstrated higher titres of antibodies reactive with CMV in patients with chronic obstructive pulmonary disease or pulmonary non-tuberculous mycobacterial (NTM) infections [48,49]. However T-cell and antibody responses to CMV rise with age [19,50], so immune activation associated with age and other infections must be considered.…”
Section: The Clinical Footprint Of CMVmentioning
confidence: 99%